Stratec SE/€SBS
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Stratec SE
**Stratec SE** is a German-based company specializing in the development and manufacturing of laboratory automation systems and diagnostics equipment. Primarily operating within the healthcare sector, its key offerings include modular and integrated systems, software solutions, and smart consumables designed to enhance laboratory workflows. Founded in 1979, Stratec has headquarters in Birkenfeld, Germany, and serves a global clientele. The company's strategic advantage lies in its ability to deliver custom OEM solutions tailored to specific partner requirements, ensuring seamless integration into existing laboratory processes. Stratec's collaboration with leading in-vitro diagnostics companies underscores its capability in providing sophisticated technological solutions.
Ticker
€SBS
Sector
Primary listing
XETRA
Industry
Health Care Equipment & Supplies
Headquarters
Employees
1,387
ISIN
DE000STRA555
Website
Stratec SE Metrics
BasicAdvanced
€326M
20.32
€1.32
0.49
-
2.24%
Price and volume
Market cap
€326M
Beta
0.49
52-week high
€28.60
52-week low
€23.05
Financial strength
Current ratio
2.474
Quick ratio
1.02
Long term debt to equity
35.301
Total debt to equity
53.821
Dividend payout ratio (TTM)
41.74%
Interest coverage (TTM)
4.91%
Profitability
EBITDA (TTM)
41.105
Gross margin (TTM)
29.65%
Net profit margin (TTM)
6.22%
Operating margin (TTM)
11.06%
Effective tax rate (TTM)
27.20%
Revenue per employee (TTM)
€190,000
Management effectiveness
Return on assets (TTM)
3.98%
Return on equity (TTM)
6.68%
Valuation
Price to earnings (TTM)
20.319
Price to revenue (TTM)
1.264
Price to book
1.34
Price to tangible book (TTM)
2.53
Price to free cash flow (TTM)
10.66
Free cash flow yield (TTM)
9.38%
Free cash flow per share (TTM)
251.23%
Forward dividend yield
2.24%
Growth
Revenue change (TTM)
-4.73%
Earnings per share change (TTM)
4.60%
3-year revenue growth (CAGR)
-3.57%
10-year revenue growth (CAGR)
5.93%
3-year earnings per share growth (CAGR)
-26.21%
10-year earnings per share growth (CAGR)
-2.34%
3-year dividend per share growth (CAGR)
-14.20%
10-year dividend per share growth (CAGR)
-1.53%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
Jul2
Stratec SE
Dividend·Payment
€0.60Per share
FAQs
What’s the current market cap for Stratec SE stock?
Stratec SE (SBS) has a market cap of €326M as of June 30, 2025.
What is the P/E ratio for Stratec SE stock?
The price to earnings (P/E) ratio for Stratec SE (SBS) stock is 20.32 as of June 30, 2025.
Does Stratec SE stock pay dividends?
No, Stratec SE (SBS) stock does not pay dividends to its shareholders as of June 30, 2025.
When is the next Stratec SE dividend payment date?
Stratec SE (SBS) stock does not pay dividends to its shareholders.
What is the beta indicator for Stratec SE?
Stratec SE (SBS) has a beta rating of 0.49. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.